“We Can’t Afford Dad's Medicine”: The Heartbreaking Reality of Late-Stage Cancer Costs
“Should we sell the house? Dad’s medication is just too expensive.” This is the agonizing question keeping a mother in her 60s and a daughter in her...
Search results for "health insurance"
Generic Drug Price Reduction: How Much Benefit Will It Bring to Patients?
These days, the pharmaceutical industry is focused on the topic of 'drug price reduction.' As the government announced its intention to lower the...
"I Don't Regret Paying Health Insurance Premiums"...What Changes for People Who Naturally Have Difficulty Stopping Bleeding?
"I live each day with anxiety. I'm afraid of getting seriously hurt if I fall. If I can't stop the bleeding, surgery...
Hospital Leaders Gather in Seoul for First Time in 19 Years, Urging Patient-Centered Care in AI Era
“Artificial intelligence will undoubtedly transform healthcare. But technology alone cannot determine the future of our...
Seoul St. Mary’s Hospital Wins 8 of 30 Awards at ICBMT 2026, Claiming Top Honors for Second Consecutive Year
The Catholic University of Korea’s Seoul St. Mary’s Hospital announced on the 20th that faculty members at its...
Fewer Radiation Sessions After Prostate Cancer Surgery Prove Equally Effective, Study Finds
Reducing the number of radiation therapy sessions intended to prevent prostate cancer recurrence by about 20 percent...
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro
Efpeglenatide, a drug candidate whose development rights were once returned by a global pharmaceutical giant, is...
Why Pancreatic Cancer Is So Hard to Catch Early—and Why Diet May Be Key
Imagine if a simple blood test could catch pancreatic cancer early. For now, that remains an ideal rather than reality.
Leading Regional Cardiac Care: Keimyung Dongsan Hospital Reaches 500 PFA Procedures in Four Month
The arrhythmia team in the Division of Cardiology at Keimyung University Dongsan Hospital has completed 500 pulsed...
MS Bio Pursues IPO to Fuel Expansion into Amniotic Lenses, Aesthetics, and Global Markets
MS Bio, a specialized manufacturer of human tissue graft materials and medical devices, is leveraging its upcoming...